questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents régulateurs de la reproduction
Contraceptifs
Contraceptifs féminins
Contraceptifs oraux
Contraceptifs oraux : Questions médicales fréquentes
Diagnostic
5
Contraceptifs oraux
Efficacité contraceptive
Contraceptifs oraux
Évaluation de la santé
Effets indésirables
Contraceptifs oraux
Contraceptifs oraux
Consultation médicale
Contraceptifs oraux
Suivi médical
Symptômes
5
Effets indésirables
Contraceptifs oraux
Douleur abdominale
Contraceptifs oraux
Cycle menstruel
Contraceptifs oraux
Saignements intermenstruels
Contraceptifs oraux
Changements d'humeur
Contraceptifs oraux
Prévention
5
Infections sexuellement transmissibles
Contraceptifs oraux
Choix contraceptif
Contraceptifs oraux
Cancer de l'ovaire
Contraceptifs oraux
Régularité
Contraceptifs oraux
Vomissements
Contraceptifs oraux
Traitements
5
Contraceptifs oraux
Adhésion au traitement
Oubli de pilule
Contraceptifs oraux
Prescription médicale
Contraceptifs oraux
Contraceptifs oraux
Post-partum
Contraceptifs oraux
Adolescents
Complications
5
Thrombose
Contraceptifs oraux
Thrombose
Contraceptifs oraux
Problèmes cardiaques
Contraceptifs oraux
Complications graves
Contraceptifs oraux
Fertilité
Contraceptifs oraux
Facteurs de risque
5
Facteurs de risque
Contraceptifs oraux
Antécédents familiaux
Contraceptifs oraux
Migraines
Contraceptifs oraux
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux : Questions médicales les plus fréquentes",
"headline": "Contraceptifs oraux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Contraceptifs oraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-28",
"dateModified": "2026-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Contraceptifs féminins",
"url": "https://questionsmedicales.fr/mesh/D003271",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs féminins",
"code": {
"@type": "MedicalCode",
"code": "D003271",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux combinés",
"alternateName": "Contraceptives, Oral, Combined",
"url": "https://questionsmedicales.fr/mesh/D003277",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux combinés",
"code": {
"@type": "MedicalCode",
"code": "D003277",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.210.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux séquentiels",
"alternateName": "Contraceptives, Oral, Sequential",
"url": "https://questionsmedicales.fr/mesh/D003279",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux séquentiels",
"code": {
"@type": "MedicalCode",
"code": "D003279",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.210.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Contraceptifs oraux synthétiques",
"alternateName": "Contraceptives, Oral, Synthetic",
"url": "https://questionsmedicales.fr/mesh/D003280",
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux synthétiques",
"code": {
"@type": "MedicalCode",
"code": "D003280",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.360.276.210.443"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Contraceptifs oraux",
"alternateName": "Contraceptives, Oral",
"code": {
"@type": "MedicalCode",
"code": "D003276",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jean-Michel Foidart",
"url": "https://questionsmedicales.fr/author/Jean-Michel%20Foidart",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Frank Z Stanczyk",
"url": "https://questionsmedicales.fr/author/Frank%20Z%20Stanczyk",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA."
}
},
{
"@type": "Person",
"name": "Mohammed AlSheef",
"url": "https://questionsmedicales.fr/author/Mohammed%20AlSheef",
"affiliation": {
"@type": "Organization",
"name": "Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia malsheef@kfmc.med.sa."
}
},
{
"@type": "Person",
"name": "Mitchell D Creinin",
"url": "https://questionsmedicales.fr/author/Mitchell%20D%20Creinin",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, California; the Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon; the Department of Obstetrics and Gynecology, University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, and the Department of Obstetrics and Gynaecology, McMaster University, Hamilton, Ontario, Canada; and Estetra SRL, an affiliate company of Mithra Pharmaceuticals, and the Department of Obstetrics and Gynecology, University of Liège, Liège, Belgium."
}
},
{
"@type": "Person",
"name": "Alison B Edelman",
"url": "https://questionsmedicales.fr/author/Alison%20B%20Edelman",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR 97239, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Paper waste and carbon emissions from oral contraceptive leaflets.",
"datePublished": "2024-10-30",
"url": "https://questionsmedicales.fr/article/39475921",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0312505"
}
},
{
"@type": "ScholarlyArticle",
"name": "Acceptability of an on-demand pericoital oral contraceptive pill: a systematic scoping review.",
"datePublished": "2024-06-28",
"url": "https://questionsmedicales.fr/article/38943120",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12978-024-01829-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "An epigenetic hypothesis for ovarian cancer prevention by oral contraceptive pill use.",
"datePublished": "2023-10-18",
"url": "https://questionsmedicales.fr/article/37853473",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13148-023-01584-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Population-based cohort study of oral contraceptive use and risk of depression.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37303201",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S2045796023000525"
}
},
{
"@type": "ScholarlyArticle",
"name": "A qualitative exploration of the over-the-counter availability of oral contraceptive pills in Australia.",
"datePublished": "2024-06-10",
"url": "https://questionsmedicales.fr/article/38857242",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0305085"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents régulateurs de la reproduction",
"item": "https://questionsmedicales.fr/mesh/D012102"
},
{
"@type": "ListItem",
"position": 6,
"name": "Contraceptifs",
"item": "https://questionsmedicales.fr/mesh/D003270"
},
{
"@type": "ListItem",
"position": 7,
"name": "Contraceptifs féminins",
"item": "https://questionsmedicales.fr/mesh/D003271"
},
{
"@type": "ListItem",
"position": 8,
"name": "Contraceptifs oraux",
"item": "https://questionsmedicales.fr/mesh/D003276"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Contraceptifs oraux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Contraceptifs oraux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Contraceptifs oraux",
"description": "Comment savoir si un contraceptif oral est efficace ?\nQuels tests sont nécessaires avant de commencer un contraceptif oral ?\nQuels signes indiquent une mauvaise tolérance au contraceptif ?\nQuand consulter un médecin après le début d'un contraceptif oral ?\nComment évaluer l'impact des contraceptifs oraux sur la santé ?",
"url": "https://questionsmedicales.fr/mesh/D003276#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Contraceptifs oraux",
"description": "Quels sont les effets secondaires courants des contraceptifs oraux ?\nLes contraceptifs oraux peuvent-ils causer des douleurs abdominales ?\nComment les contraceptifs oraux affectent-ils le cycle menstruel ?\nPeut-on avoir des saignements entre les règles avec des contraceptifs ?\nLes contraceptifs oraux peuvent-ils provoquer des changements d'humeur ?",
"url": "https://questionsmedicales.fr/mesh/D003276#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Contraceptifs oraux",
"description": "Les contraceptifs oraux protègent-ils contre les IST ?\nComment choisir le bon contraceptif oral ?\nLes contraceptifs oraux peuvent-ils réduire le risque de cancer ?\nQuelle est l'importance de la régularité dans la prise des pilules ?\nLes contraceptifs oraux sont-ils efficaces en cas de vomissements ?",
"url": "https://questionsmedicales.fr/mesh/D003276#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Contraceptifs oraux",
"description": "Comment prendre correctement un contraceptif oral ?\nQue faire en cas d'oubli d'une pilule contraceptive ?\nLes contraceptifs oraux nécessitent-ils une prescription ?\nPeut-on utiliser des contraceptifs oraux après un accouchement ?\nLes contraceptifs oraux sont-ils adaptés aux adolescentes ?",
"url": "https://questionsmedicales.fr/mesh/D003276#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Contraceptifs oraux",
"description": "Quels sont les risques associés aux contraceptifs oraux ?\nComment reconnaître une thrombose liée aux contraceptifs ?\nLes contraceptifs oraux peuvent-ils causer des problèmes cardiaques ?\nQuels signes doivent alerter sur une complication grave ?\nLes contraceptifs oraux peuvent-ils affecter la fertilité future ?",
"url": "https://questionsmedicales.fr/mesh/D003276#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Contraceptifs oraux",
"description": "Qui devrait éviter les contraceptifs oraux ?\nLes antécédents familiaux influencent-ils l'utilisation des contraceptifs ?\nLe poids corporel affecte-t-il l'efficacité des contraceptifs oraux ?\nLes femmes ayant des migraines doivent-elles être prudentes ?\nL'âge influence-t-il la décision d'utiliser des contraceptifs oraux ?",
"url": "https://questionsmedicales.fr/mesh/D003276#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment savoir si un contraceptif oral est efficace ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est généralement supérieure à 99% lorsqu'il est pris correctement."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires avant de commencer un contraceptif oral ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen médical et parfois des tests sanguins pour évaluer la santé hormonale."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une mauvaise tolérance au contraceptif ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires comme des nausées, des maux de tête ou des saignements irréguliers."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin après le début d'un contraceptif oral ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si des effets secondaires graves ou des symptômes inhabituels apparaissent."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des contraceptifs oraux sur la santé ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les effets sur le cycle menstruel et les symptômes physiques au fil du temps."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants des contraceptifs oraux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, maux de tête, changements d'humeur et saignements irréguliers."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux peuvent-ils causer des douleurs abdominales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines femmes peuvent ressentir des douleurs abdominales légères."
}
},
{
"@type": "Question",
"name": "Comment les contraceptifs oraux affectent-ils le cycle menstruel ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils régulent le cycle, réduisent les saignements et peuvent diminuer les douleurs."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des saignements entre les règles avec des contraceptifs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements intermenstruels peuvent survenir, surtout au début du traitement."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux peuvent-ils provoquer des changements d'humeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des fluctuations hormonales peuvent entraîner des changements d'humeur chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux protègent-ils contre les IST ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne protègent pas contre les infections sexuellement transmissibles."
}
},
{
"@type": "Question",
"name": "Comment choisir le bon contraceptif oral ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin pour évaluer vos besoins et votre santé avant de choisir."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux peuvent-ils réduire le risque de cancer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire le risque de cancer de l'ovaire et de l'endomètre."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la régularité dans la prise des pilules ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La régularité est cruciale pour maintenir des niveaux hormonaux stables et éviter les échecs."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux sont-ils efficaces en cas de vomissements ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si vomissements surviennent dans les 2 heures suivant la prise, il faut reprendre la pilule."
}
},
{
"@type": "Question",
"name": "Comment prendre correctement un contraceptif oral ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prenez-le chaque jour à la même heure pour maximiser son efficacité."
}
},
{
"@type": "Question",
"name": "Que faire en cas d'oubli d'une pilule contraceptive ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prenez-la dès que possible, mais ne doublez pas la dose. Consultez les instructions."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux nécessitent-ils une prescription ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils nécessitent généralement une prescription médicale après évaluation."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des contraceptifs oraux après un accouchement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est conseillé d'attendre quelques semaines et de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux sont-ils adaptés aux adolescentes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être prescrits aux adolescentes après évaluation médicale appropriée."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés aux contraceptifs oraux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Risques incluent thrombose, AVC et hypertension, surtout chez les fumeuses."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une thrombose liée aux contraceptifs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent douleur, gonflement d'une jambe, ou essoufflement soudain."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux peuvent-ils causer des problèmes cardiaques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent augmenter le risque de problèmes cardiaques chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels signes doivent alerter sur une complication grave ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs thoraciques, maux de tête sévères, ou vision floue nécessitent une consultation immédiate."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux peuvent-ils affecter la fertilité future ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur utilisation n'affecte généralement pas la fertilité après l'arrêt."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter les contraceptifs oraux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Femmes fumeuses de plus de 35 ans, ayant des antécédents de thrombose ou AVC."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils l'utilisation des contraceptifs ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies cardiovasculaires peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Le poids corporel affecte-t-il l'efficacité des contraceptifs oraux ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un IMC élevé peut réduire l'efficacité des contraceptifs oraux."
}
},
{
"@type": "Question",
"name": "Les femmes ayant des migraines doivent-elles être prudentes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines avec aura augmentent le risque d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la décision d'utiliser des contraceptifs oraux ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes de plus de 35 ans doivent être évaluées pour des risques accrus."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 19/04/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Publications dans "Contraceptifs oraux" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia malsheef@kfmc.med.sa.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, California; the Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon; the Department of Obstetrics and Gynecology, University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, and the Department of Obstetrics and Gynaecology, McMaster University, Hamilton, Ontario, Canada; and Estetra SRL, an affiliate company of Mithra Pharmaceuticals, and the Department of Obstetrics and Gynecology, University of Liège, Liège, Belgium.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR 97239, USA.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Dinox BV, Groningen, The Netherlands.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Dinox BV, Groningen, The Netherlands.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Estetra SRL, An Affiliate's Company of Mithra Pharmaceuticals, Liège, Belgium.
Publications dans "Contraceptifs oraux" :
2 publications dans cette catégorie
Affiliations :
Estetra SRL, An Affiliate's Company of Mithra Pharmaceuticals, Liège, Belgium. Electronic address: mjost@mithra.com.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
Department of Anaesthetics, Wollongong Hospital, Wollongong.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
Department of Anaesthetics, Wollongong Hospital, Wollongong.
Department of Anaesthetics, St George Hospital, Kogarah.
School of Clinical Medicine, University of New South Wales, Kensington.
Graduate School Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España. Electronic address: celiareq@hotmail.com.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
Departments of Bioengineering and Mechanical Engineering, Northeastern University, Boston, MA 02115, USA.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Publications dans "Contraceptifs oraux" :
1 publication dans cette catégorie
Affiliations :
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Publications dans "Contraceptifs oraux" :
Oral contraceptives (OC) are the most used form of contraception among women in the U.S. and Europe. Like other medications, their packaging must include patient information leaflets. This study quant...
Access to an on-demand pericoital oral contraceptive pill - used to prevent pregnancy within a defined window around sexual intercourse - could offer women more reproductive agency. A contraceptive wi...
Systematic scoping review, comprising 30 peer-reviewed papers published between 2014-2023....
Data from 30 papers reporting on research from 16 countries across five World Health Organisation regions suggests widespread user appeal for on-demand oral contraceptive pills that can be used peri- ...
Introduction of an on-demand pericoital oral contraceptive pill could expand contraceptive choice for diverse women experiencing unmet need for modern contraception and constrained sexual and reproduc...
Ovarian cancer is the second most common gynecological cancer type after uterine cancers. In 2020, according to worldwide statistics, there were more than 313,000 new cases of ovarian cancer. Most con...
There is now increasing data reporting the role of epigenetic changes, which are detectable in ovarian cancer tumors, suggesting the possibility that epigenetics may also play a key role in the mechan...
This review focusses on the evidence for a proposed novel hypothesis-that COCPs act as a chemoprevention through the impact on the epigenome of the cells of origin of ovarian cancer-fallopian tubes ep...
Research on the effect of oral contraceptive (OC) use on the risk of depression shows inconsistent findings, especially in adult OC users. One possible reason for this inconsistency is the omission of...
This is a population-based cohort study based on data from 264,557 women from the UK Biobank. Incidence of depression was addressed via interviews, inpatient hospital or primary care data. The hazard ...
We observed that the first 2 years of OC use were associated with a higher rate of depression compared to never users (HR = 1.71, 95% confidence interval [CI]: 1.55-1.88). Although the risk was not as...
Our findings suggest that the use of OCs, particularly during the first 2 years, increases the risk of depression. Additionally, OC use during adolescence might increase the risk of depression later i...
The prevention of unintended pregnancy is a public health issue affecting women worldwide. In Australia, women are required to get a prescription to obtain the oral contraceptive pill (OCP), which may...
A mixed methods approach was used to explore women's preferences regarding access to the OCP. Focus group discussions (FGDs) were conducted to organically identify the preferences followed by an empir...
Thematic analysis revealed that women perceived OTC availability of OCPs as a mechanism to increase the accessibility of contraception by reducing cost, travel time, waiting time, and increasing openi...
The participants expressed their support for reclassifying OCPs to OTC, particularly for repeat prescriptions, as it would save valuable resources and time. However, some safety and logistical issues ...
The link between oral contraceptive pill (OCP) and depression is still unclear. This work analyses the prevalence and correlates of major depression in US women using OCP....
This study used the National Health and Nutrition Examination Survey (NHANES) 2005-2012 data to provide the prevalence and correlates of major depression in women using OCP. Major depression was defin...
A total of 6239 women aged 18-55 years were included in the present analysis. Current OCP users had a lower prevalence of major depression (4.6 %; 95 % CI, 3.2 to 6.6) compared to former users of OCP ...
This is a cross-sectional study....
The prevalence of major depression among women using OCP may be lower than in former users of OCP, however, the burden of depression remains high. Further research with longitudinal follow-up for depr...
SERPINC1 is a glycoprotein that regulates blood coagulation. SERPINC1 congenital or acquired deficiencies represent a significant risk factor for thromboembolic disease. SERPINC1 acquired defects are ...
A 50-year-old Caucasian woman who took gestodene 75 µg/ethinylestradiol 20 µg as oral contraceptive, was sent to our thrombophilia clinic because, on thrombophilia testing, a reduction of SERPINC1 (74...
Each patient has a different sensitivity to contraceptive use. Genetic (or epigenetic) regulation of anticoagulant proteins might account for a different rate of consumption of anticoagulant proteins ...
Women living in high-quality healthcare systems are more likely to use oral contraceptives at some point in their lives. Research findings have sparked controversial discussions about contraception in...
A concurrent explanatory mixed-methods design was used to conduct content analysis of German YouTube videos. The information from 175 videos of 158 individuals was extracted through quantitative descr...
The body was a recurring theme in the pill biographies. Women described, for example, bodily sensations as reasons for taking and stopping the pill. They also described positive and negative side effe...
The study identified key symptoms of oral contraceptive initiation and discontinuation by portraying the experiences of female YouTubers, adding valuable insights to the understanding of method initia...
The US Supreme Court Dobbs v Jackson Women's Health Organization decision allowed states to strengthen restrictions on abortion access, triggering the closure of family planning clinics and leading to...
To evaluate the association between the Dobbs decision and fills for oral and emergency contraceptives in states that enacted the most restrictive abortion policies after Dobbs....
This cohort study used data on contraceptive fills for women of reproductive age (15-49 years) in the US from IQVIA's National Prescription Audit PayerTrak and data from the Guttmacher Institute were ...
State-level abortion restrictions....
Monthly fills of OCPs and ECs per 100 000 women of reproductive age....
Between March 2021 and October 2023, 142.8 million prescriptions for OCPs and 904 269 prescriptions for ECs were dispensed at US retail pharmacies. Before Dobbs, trends in monthly fill rates were simi...
In this cohort study of prescriptions filled at US pharmacies, the Dobbs decision was associated with declines in oral contraceptives, particularly ECs, in states enacting the most restrictive abortio...
The political instability, economic crisis, and devaluation of the national currency left Lebanese females suffering from a scarcity of oral contraceptive pills (OCPs). Therefore, we aimed to identify...
Community pharmacies were selected randomly across Lebanon, using a stratified sampling approach, where female clients asking for OCPs were interviewed using a standardized data collection form....
A total of 440 females were interviewed. More than three-quarters of the participants (76.4%) reported not finding their preferred OCPs brands, almost 40% were affected by the increased prices, and 28...
OCPs shortage has seriously and negatively exposed women to various undesirable consequences including unplanned pregnancy and dysregulation of menses. Therefore, there is an urgent need to bring the ...